Distal anastomotic lesions after coronary artery bypass surgery: Incidence, pathogenesis, and treatment approach

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Catheterization and cardiovascular interventions

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccd.24582PMID 22888036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current status, challenges and future directions of drug-eluting balloons.

  2011cited by this paper
• Drug-eluting balloon: the comeback kid?

  2009cited by this paper
• Serum chitotriosidase activity in patients with coronary artery disease.

  2008cited by this paper
• Percutaneous transluminal angioplasty to left internal mammary artery grafts: immediate and long-term clinical outcomes.

  2007cited by this paper
• Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery

  2007cited by this paper
• Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts.

  2006cited by this paper
• Comparison of saphenous vein and internal thoracic artery graft patency by coronary system.

  2005cited by this paper
• Results of angioplasty (with or without stent) at the site of a narrowed coronary anastomosis of the left internal mammary artery graft or via the internal mammary artery.

  2004cited by this paper
• Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.

  2004cited by this paper
• Clinical outcomes following stent implantation in internal mammary artery grafts

  2003cited by this paper
• Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes.

  2000cited by this paper
• In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site.

  1999cited by this paper
• Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors.

  1998cited by this paper
• Internal mammary artery graft angioplasty: acute and long-term outcome.

  1998cited by this paper
• Management of restenosis after coronary intervention.

  1996cited by this paper
• Initial and subsequent angiographic outcome of percutaneous transluminal angioplasty performed on internal mammary artery grafts.

  1995cited by this paper
• Percutaneous approaches to recurrent myocardial ischemia in patients with prior surgical revascularization.

  1994cited by this paper
• Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts.

  1993cited by this paper
• Long-term angiographic follow-up after angioplasty of venous coronary bypass grafts.

  1991cited by this paper
• Coronary bypass graft fate: long-term angiographic study.

  1991cited by this paper
• Percutaneous transluminal angioplasty involving internal mammary artery grafts.

  1991cited by this paper
• Reoperation for Coronary Atherosclerosis: Changing Practice in 2509 Consecutive Patients

  1990cited by this paper
• Coronary angioplasty after coronary bypass surgery: initial results and late outcome in 422 patients.

  1990cited by this paper
• Early postoperative balloon coronary angioplasty for failed coronary artery bypass grafting.

  1990cited by this paper
• Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up.

  1989cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with two or more previous coronary artery bypass grafting operations.

  1988cited by this paper
• Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft.

  1988cited by this paper
• Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts.

  1988cited by this paper
• Percutaneous transluminal angioplasty of stenotic coronary artery bypass grafts: 5 years' experience.

  1987cited by this paper
• Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.

  1985cited by this paper
• Angina pectoris and coronary bypass surgery: patterns of prevalence and recurrence in 3105 consecutive patients followed up to 11 years.

  1984cited by this paper
• The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

  1984cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery.

  1984cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery.

  1983cited by this paper
• The internal mammary artery graft. Its longevity after coronary bypass.

  1981cited by this paper
• The efficacy of coronary artery surgery.

  1981cited by this paper
• Long-term Serial Angiographic Studies After Coronary Artery Bypass Surgery

  1979cited by this paper
• Coronary Bypass Graft Fate: Angiographic Grading of 1400 Consecutive Grafts Early after Operation and of 1132 after One Year

  1978cited by this paper

• [Microsurgical technique in coronary bypass surgery: possibilities, perspectives and limitations].

  2019cites this paper